Tech Company Financing Transactions

GliaCure Funding Round

On 8/5/2014, GliaCure received $5.8 million in Series B financing from private investors.

Transaction Overview

Company Name
Announced On
8/5/2014
Transaction Type
Venture Equity
Amount
$5,800,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
33 East Main St. 440
Madison, WI 53703
USA
Email Address
Overview
GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets.
Profile
GliaCure LinkedIn Company Profile
Social Media
GliaCure Company Twitter Account
Company News
GliaCure News
Facebook
GliaCure on Facebook
YouTube
GliaCure on YouTube

Management Team

Title
Name
Email & Social
President
Michael Szulczewski
  Michael Szulczewski LinkedIn Profile  Michael Szulczewski Twitter Account  Michael Szulczewski News  Michael Szulczewski on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/5/2014: Retention Science venture capital transaction
Next: 8/5/2014: SecureAuth venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary